Liposuction Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the liposuction devices market size is projected to expand from USD 2.88 billion in 2025 and USD 3.17 billion in 2026 to USD 5.44 billion by 2031, registering a CAGR of 11.39% between 2026 to 2031.

This report is Segmented by Technology/Modality (Suction-Assisted, Ultrasound-Assisted, and More), Product Type (Portable Systems, Stand-Alone Systems), End User (Hospitals, and More), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Liposuction Devices Market Trends and Insights

Liposuction Volumes at Record Highs; Shift to High-Definition Contouring

Aggregate procedures reached historic highs in developed regions, yet underlying demand now centers on athletic etching rather than bulk extraction. High-definition sculpting depends on ultrasound and laser devices that selectively emulsify fibrous zones. The "skinny BBL" exemplifies low-volume, shape-focused grafting among patients with body mass indices below 23. Precision harvest elevates the role of closed-loop cannulae and real-time imaging, motivating manufacturers toward integrated, small-footprint consoles. Global procedure divergence-expansion in the United States versus softness in some emerging economies-illustrates how currency swings and shifts in discretionary spending alter the regional mix without suppressing overall demand.

Rapid Adoption of Energy-Assisted Modalities

Ultrasound-, power-, and laser-assisted systems shorten operating time and reduce surgeon fatigue; MicroAire's PAL platform extracted significantly more volume per minute than manual suction in company trials. Laser devices add thermal coagulation, reducing bruising and stimulating collagen renewal, enabling combined liposuction and tightening in a single session. Apyx Medical's AYON, cleared in May 2025, channels helium plasma for controlled subsurface coagulation and is already pursuing a power-assisted indication. Bundling multiple energy sources into a single console reduces practice capital outlay and simplifies staff training, spurring rapid replacement of legacy suction-only machines in premium markets.

Non-Invasive Body-Contouring Alternatives Divert Spend from Surgical Lipo

Cryolipolysis, HIFU, and injectable lipolytics satisfy a risk-averse cohort that values zero downtime. AbbVie's CoolSculpting delivers an 8.6% reduction in fat layer in 12 weeks with no anesthesia, siphoning patients who might otherwise book suction procedures. Medical-spa rollout is easier than surgical-suite investment, but it fragments discretionary dollars and tapers device utilization rates in some urban markets.

Other drivers and restraints analyzed in the detailed report include:

1. Migration to Outpatient Settings Enabled by Tumescent Anesthesia
2. APAC Demand Acceleration via Medical Tourism and Rising Middle-Class Incomes
3. Regulatory and Safety Communications Temper Energy-Device Adoption

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Suction-assisted devices accounted for 46.9% of 2025 revenue and are projected to post a 12.1% CAGR, anchoring the liposuction devices market size leadership. The technique's simplicity, low capital entry, and surgeon familiarity support its share, even as ultrasound, power, and laser systems pitch precision benefits.

Energy-assisted platforms are penetrating high-definition and fibrous-tissue cases in North America and Western Europe. Laser and plasma variants bundle coagulation and tightening, thereby enhancing the procedure's value. Yet hospitals and price-sensitive clinics still default to cost-efficient suction-only consoles, slowing modal shift and keeping the liposuction devices market share of traditional systems resilient.

Geography Analysis

North America generated 52.86% of 2025 revenue, powered by 349,728 U.S. procedures and CMS reimbursement clarity that favors ASC-based operations. Canada supplies complementary demand, while Mexico attracts cross-border patients seeking cost relief. Non-invasive competition is strongest here, yet energy-assisted innovators remain headquartered in the region, sustaining premium device sales.

Europe delivered steadily, if slower, uptake, constrained by advertising curbs that dampen youthful interest and macroeconomic caution in major economies. Germany's 80,519-procedure base anchors continental volumes, with the United Kingdom, France, and Italy rounding out the top tier. Stricter marketing codes are nudging clinics to emphasize safety credentials over glamor, influencing modal mix toward ultrasound and RF systems with published evidence.

Asia-Pacific is on track for a 12.0% CAGR, driven by surgical tourism corridors in Thailand and South Korea, and by a swelling urban middle class across China and Indonesia. China's regulatory streamlining prompted Solta's 2025 distributor acquisition, underscoring long-run commitment. India, fourth worldwide in 2023 cases, benefits from English-language care and cost arbitrage, placing the region at the vanguard of future growth in the liposuction devices market.

1. Alma Lasers
2. Apyx Medical
3. Ardo Medical
4. BIcakcIlar
5. Black & Black Surgical
6. CHEIRON
7. Cynosure
8. DEKA
9. Euromi
10. Genesis Biosystems
11. Human Med
12. InMode
13. M.D. Resource
14. MicroAire
15. Moller Medical
16. Nouvag
17. Solta Medical
18. Tulip Medical Products
19. Wells Johnson

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support